IFITM3 is thus a regulator of the TGFβ/Smad/MAPK signaling pathway through the direct interaction between IFITM3 and Smad4, promoting the EMT, cell proliferation, migration and bone metastasis in prostate cancer (63). This evidence concerns the gene IFITM3 and prostate cancer.